Valbenazine    (DrugBank: Valbenazine)

1 disease
IDDisease name (Link within this page)Number of trials
8Huntington disease2

8. Huntington disease    [ 197 clinical trials,   171 drugs,   (DrugBank: 54 drugs),   82 drug target genes,   144 drug target pathways]
Searched query = "Huntington disease", "Huntington chorea"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.
2 / 197 trials found
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT04400331
(ClinicalTrials.gov)
September 18, 202019/5/2020Open-Label Rollover Study for Continuing Valbenazine Administration for the Treatment of Chorea Associated With Huntington DiseaseOpen-Label Rollover Study for Continuing Valbenazine Administration for the Treatment of Chorea Associated With Huntington DiseaseChorea, HuntingtonDrug: ValbenazineNeurocrine BiosciencesHuntington Study GroupEnrolling by invitation18 Years75 YearsAll120Phase 3United States
2NCT04102579
(ClinicalTrials.gov)
November 13, 201923/9/2019Efficacy, Safety, and Tolerability of Valbenazine for the Treatment of Chorea Associated With Huntington DiseaseA Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Assess the Efficacy, Safety, and Tolerability of Valbenazine for the Treatment of Chorea Associated With Huntington DiseaseChorea, HuntingtonDrug: Valbenazine;Drug: PlaceboNeurocrine BiosciencesHuntington Study GroupRecruiting18 Years75 YearsAll120Phase 3United States;Canada